BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 22544007)

  • 1. Which rivastigmine formula is better for heart in elderly patients with Alzheimer's disease: oral or patch?
    Isik AT; Soysal P; Yay A
    Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):735-8. PubMed ID: 24867375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report.
    Fratta KA; Ginder M; Haggerty DA
    J Emerg Med; 2023 Oct; 65(4):e366-e368. PubMed ID: 37716903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.
    Whitledge JD; Watson CJ; Simpson M; Bakkar A; Boussi L; Scott M; Boyle KL
    J Med Toxicol; 2023 Apr; 19(2):219-223. PubMed ID: 36575250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription of transdermal patches in Colombia: A real-world evidence study.
    Valladales-Restrepo LF; Gaviria-Mendoza A; Londoño-Serna MJ; Ospina-Cano JA; Giraldo-Giraldo C; Machado-Duque ME; Machado-Alba JE
    Int J Risk Saf Med; 2023; 34(4):325-335. PubMed ID: 36776078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter in Response to Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report.
    Jenrette JE; Lebin JA
    J Emerg Med; 2024 Feb; 66(2):262-263. PubMed ID: 38432708
    [No Abstract]   [Full Text] [Related]  

  • 6. Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type.
    Dhillon S
    Drugs; 2011 Jun; 71(9):1209-31. PubMed ID: 21711064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.
    Pregelj P
    Psychogeriatrics; 2012 Sep; 12(3):165-71. PubMed ID: 22994614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transdermal rivastigmine patch in outpatient services in Austria: a naturalistic study in 103 patients with Alzheimer dementia].
    Schmidt R; Alf C; Bancher C; Benke T; Berek K; Dal-Bianco P; Führwürth G; Imarhiagbe D; Jagsch C; Lechner A; Rainer M; Reisecker F; Rotaru J; Uranüs M; Walter A; Winkler A; Wuschitz A
    Neuropsychiatr; 2009; 23(1):58-63. PubMed ID: 19272293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.
    Winblad B; Grossberg G; Frölich L; Farlow M; Zechner S; Nagel J; Lane R
    Neurology; 2007 Jul; 69(4 Suppl 1):S14-22. PubMed ID: 17646619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule.
    Winblad B; Cummings J; Andreasen N; Grossberg G; Onofrj M; Sadowsky C; Zechner S; Nagel J; Lane R
    Int J Geriatr Psychiatry; 2007 May; 22(5):456-67. PubMed ID: 17380489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis.
    Farlow MR; Alva G; Meng X; Olin JT
    Curr Med Res Opin; 2010 Feb; 26(2):263-9. PubMed ID: 19929593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do local meteorological conditions influence skin irritation caused by transdermal rivastigmine? A retroprospective, pilot study.
    Segers K; Cytryn E; Surquin M
    J Clin Psychopharmacol; 2012 Jun; 32(3):412-5. PubMed ID: 22544007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia.
    Darreh-Shori T; Jelic V
    Expert Opin Drug Saf; 2010 Jan; 9(1):167-76. PubMed ID: 20021294
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.